Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells
- 15 December 1994
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 59 (6) , 808-813
- https://doi.org/10.1002/ijc.2910590617
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A 90-kDa Protein Serum Marker for the Prediction of Progression to AIDS in a Cohort of HIV-1+Homosexual MenAIDS Research and Human Retroviruses, 1993
- Cloning and characterization of cyclophilin C-associated protein: a candidate natural cellular ligand for cyclophilin C.Proceedings of the National Academy of Sciences, 1993
- Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma.Proceedings of the National Academy of Sciences, 1993
- Purification and characterization of a 90 kDa protein released from human tumors and tumor cell linesFEBS Letters, 1993
- Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of diseaseBritish Journal of Cancer, 1993
- An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors.Proceedings of the National Academy of Sciences, 1990
- Recombinant human leukocyte interferon‐α 2b stimulates the synthesis and release of a 90k tumor‐associated antigen in human breast cancer cellsInternational Journal of Cancer, 1988
- Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patientsBreast Cancer Research and Treatment, 1988
- Recombinant Interferon Enhances Monoclonal Antibody-Targeting of Carcinoma Lesions in VivoScience, 1987
- Enhanced expression of β 2 -microglobulin and HLA antigens on human lymphoid cells by interferonProceedings of the National Academy of Sciences, 1978